NZ744340A - Anti-jagged1 antibodies and methods of use - Google Patents

Anti-jagged1 antibodies and methods of use

Info

Publication number
NZ744340A
NZ744340A NZ744340A NZ74434015A NZ744340A NZ 744340 A NZ744340 A NZ 744340A NZ 744340 A NZ744340 A NZ 744340A NZ 74434015 A NZ74434015 A NZ 74434015A NZ 744340 A NZ744340 A NZ 744340A
Authority
NZ
New Zealand
Prior art keywords
methods
jagged1 antibodies
jagged1
antibodies
same
Prior art date
Application number
NZ744340A
Inventor
Yan Wu
Christian W Siebel
Yvonne Chinn
Julie Q Hang
Daniel Lafkas
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NZ744340A publication Critical patent/NZ744340A/en

Links

Abstract

The invention provides anti-Jagged1 antibodies and methods of using the same.
NZ744340A 2014-02-12 2015-02-11 Anti-jagged1 antibodies and methods of use NZ744340A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461939110P 2014-02-12 2014-02-12
NZ72245715 2015-02-11

Publications (1)

Publication Number Publication Date
NZ744340A true NZ744340A (en) 2020-01-31

Family

ID=69184831

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ744340A NZ744340A (en) 2014-02-12 2015-02-11 Anti-jagged1 antibodies and methods of use

Country Status (1)

Country Link
NZ (1) NZ744340A (en)

Similar Documents

Publication Publication Date Title
ZA202107931B (en) Anti-tau antibodies and methods of use
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
PH12017500877B1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
PH12016501894B1 (en) Anti-ox40 antibodies and methods of use
MX2017005920A (en) Anti-tim3 antibodies and methods of use.
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
PH12017500322A1 (en) Anti-her2 antibodies and immunoconjugates
MA40579A (en) Anti-cll-1 antibodies and immunoconjugates
CR20230163A (en) Anti-tau antibodies and methods of use
MX2015012326A (en) Anti-crth2 antibodies and their use.
MX2017010667A (en) Anti-pvrig antibodies and methods of use.
MY176285A (en) Anti-fcrh5 antibodies
WO2018081648A8 (en) Anti-mic antibodies and methods of use
MX2016015162A (en) Anti-gpc3 antibodies and immunoconjugates.
MX2019006330A (en) Anti-tau antibodies and methods of their use.
MX2016004853A (en) ANTI-Ly6E ANTIBODIES AND METHODS OF USE.
MX2016016233A (en) Anti-lgr5 antibodies and uses thereof.
MX2016015280A (en) Anti-brdu antibodies and methods of use.
MX2015010789A (en) Anti-mcsp antibodies.
NZ744340A (en) Anti-jagged1 antibodies and methods of use

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 FEB 2022 BY THOMSON REUTERS

Effective date: 20210112

LAPS Patent lapsed